Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (31-40 of 287) with videos related to

Pageof 29
Sort By:
Gastroenterology|May 29, 2004
Optimizing anti-TNF treatment in inflammatory bowel diseasePaul Rutgeerts, Gert Van Assche, Séverine Vermeire
Current Opinion in Gastroenterology|June 3, 2005
Medical treatment of inflammatory bowel diseasesGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Inflammatory Bowel Diseases|September 26, 2008
What can we expect from endoscopic dilation of the stenotic tract in Crohn's disease?Gert Van Assche, Séverine Vermeire, Paul Rutgeerts
F1000 Medicine Reports|December 21, 2010
Vaccination and infection prevention in inflammatory bowel diseaseSeverine Vermeire, Gert Van Assche, Paul Rutgeerts
Gut|February 13, 2009
Genetic analysis to predict prognosis at the onset of Crohn's disease: not yet ready for prime time?Severine Vermeire, Gert Van Assche, Paul Rutgeerts
Gut|March 21, 2007
Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?Paul Rutgeerts, Severine Vermeire, Gert Van Assche
European Journal of Pharmacology|October 20, 2009
Infliximab therapy for patients with inflammatory bowel disease: 10 years onGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Gastroenterology|March 2, 2010
Postinfectious irritable bowel syndrome: a genetic link identified?Séverine Vermeire, Gert Van Assche, Paul Rutgeerts
Current Drug Targets|March 10, 2010
Mucosal healing and anti TNFs in IBDGert van Assche, Séverine Vermeire, Paul Rutgeerts
World Journal of Gastroenterology|September 24, 2008
Treatment of severe steroid refractory ulcerative colitisGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Pageof 29

Showing results (31-40 of 287) with videos related to

Sort By:
Pageof 29
Gastroenterology|May 29, 2004
Optimizing anti-TNF treatment in inflammatory bowel diseasePaul Rutgeerts, Gert Van Assche, Séverine Vermeire
Current Opinion in Gastroenterology|June 3, 2005
Medical treatment of inflammatory bowel diseasesGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Inflammatory Bowel Diseases|September 26, 2008
What can we expect from endoscopic dilation of the stenotic tract in Crohn's disease?Gert Van Assche, Séverine Vermeire, Paul Rutgeerts
F1000 Medicine Reports|December 21, 2010
Vaccination and infection prevention in inflammatory bowel diseaseSeverine Vermeire, Gert Van Assche, Paul Rutgeerts
Gut|February 13, 2009
Genetic analysis to predict prognosis at the onset of Crohn's disease: not yet ready for prime time?Severine Vermeire, Gert Van Assche, Paul Rutgeerts
Gut|March 21, 2007
Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?Paul Rutgeerts, Severine Vermeire, Gert Van Assche
European Journal of Pharmacology|October 20, 2009
Infliximab therapy for patients with inflammatory bowel disease: 10 years onGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Gastroenterology|March 2, 2010
Postinfectious irritable bowel syndrome: a genetic link identified?Séverine Vermeire, Gert Van Assche, Paul Rutgeerts
Current Drug Targets|March 10, 2010
Mucosal healing and anti TNFs in IBDGert van Assche, Séverine Vermeire, Paul Rutgeerts
World Journal of Gastroenterology|September 24, 2008
Treatment of severe steroid refractory ulcerative colitisGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Pageof 29